152 related articles for article (PubMed ID: 37551941)
41. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
Argoff CE; Alford DP; Fudin J; Adler JA; Bair MJ; Dart RC; Gandolfi R; McCarberg BH; Stanos SP; Gudin JA; Polomano RC; Webster LR
Pain Med; 2018 Jan; 19(1):97-117. PubMed ID: 29206984
[TBL] [Abstract][Full Text] [Related]
42. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
Whitley P; LaRue L; Fernandez SA; Passik SD; Dawson E; Jackson RD
JAMA Netw Open; 2022 Jun; 5(6):e2215425. PubMed ID: 35657623
[TBL] [Abstract][Full Text] [Related]
43. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review.
Davis CS; Lieberman AJ; Hernandez-Delgado H; Suba C
Drug Alcohol Depend; 2019 Jan; 194():166-172. PubMed ID: 30445274
[TBL] [Abstract][Full Text] [Related]
44. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
Sehgal N; Manchikanti L; Smith HS
Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
[TBL] [Abstract][Full Text] [Related]
45. Opioid Prescribing Laws and Emergency Department Guidelines for Chronic Non-Cancer Pain in Washington State.
Skaer TL; Nwude AC
Pain Pract; 2016 Jun; 16(5):642-7. PubMed ID: 26369588
[TBL] [Abstract][Full Text] [Related]
46. Provider reasons for discontinuing long-term opioid therapy following aberrant urine drug tests differ based on the type of substance identified.
Wyse JJ; Morasco BJ; Dobscha SK; Demidenko MI; Meath THA; Lovejoy TI
J Opioid Manag; 2018; 14(4):295-303. PubMed ID: 30234926
[TBL] [Abstract][Full Text] [Related]
47. Using urine drug testing to support healthy boundaries in clinical care.
Heit HA; Gourlay DL
J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
[TBL] [Abstract][Full Text] [Related]
48. Blood testing in chronic pain management.
Deer TR; Gunn J
Pain Physician; 2015; 18(2):E157-61. PubMed ID: 25794214
[TBL] [Abstract][Full Text] [Related]
49. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
50. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
51. Exemptions to state laws regulating opioid prescribing for patients with cancer-related pain: A summary.
Bulls HW; Bell LF; Orris SR; Goodin BR; Liebschutz JM; Wozniak A; Merlin JS; Schenker Y
Cancer; 2021 Sep; 127(17):3137-3144. PubMed ID: 34043811
[TBL] [Abstract][Full Text] [Related]
52. Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.
Turner JA; Saunders K; Shortreed SM; Rapp SE; Thielke S; LeResche L; Riddell KM; Von Korff M
J Gen Intern Med; 2014 Feb; 29(2):305-11. PubMed ID: 24142119
[TBL] [Abstract][Full Text] [Related]
53. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
Lawrence R; Mogford D; Colvin L
Br J Anaesth; 2017 Dec; 119(6):1092-1109. PubMed ID: 28981581
[TBL] [Abstract][Full Text] [Related]
54. FDA/DEA/PDMP/UDT: alphabet soup or sensible and integrated risk management?
Passik SD; Kirsh KL; Twillman RK
J Opioid Manag; 2015; 11(1):77-81. PubMed ID: 25750168
[TBL] [Abstract][Full Text] [Related]
55. Opioids, pain management and the law.
Stayner RS; Copenhaver DJ
Curr Opin Anaesthesiol; 2012 Oct; 25(5):566-71. PubMed ID: 22914352
[TBL] [Abstract][Full Text] [Related]
56. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC).
Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C
Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149
[TBL] [Abstract][Full Text] [Related]
57. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
[TBL] [Abstract][Full Text] [Related]
58. Opioid and cocaine use among primary care patients on buprenorphine-Self-report and urine drug tests.
Bagley SM; Cheng DM; Winter M; Alford DP; LaBelle C; Walley AY; Samet JH
Drug Alcohol Depend; 2018 Nov; 192():245-249. PubMed ID: 30290291
[TBL] [Abstract][Full Text] [Related]
59. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
60. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
